ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Noda
|
11K |
5.3M |
7 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
11K
|
5.3M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide Rett syndrome clinical trial in girls aged 2-5
|
|
Noda
|
30 |
15K |
36 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
30
|
15K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q2 2020 Activity Report and Cash Flow Report
|
|
Noda
|
9 |
5.9K |
6 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
9
|
5.9K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
Noda
|
38 |
17K |
4 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
38
|
17K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
113 |
44K |
6 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
113
|
44K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
113 |
44K |
11 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
113
|
44K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: International institution acquires 14% of Neuren
|
|
Noda
|
86 |
44K |
11 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
86
|
44K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: International institution acquires 14% of Neuren
|
|
Noda
|
86 |
44K |
4 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
86
|
44K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: International institution acquires 14% of Neuren
|
|
Noda
|
86 |
44K |
12 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
86
|
44K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Temporary pause in new enrolments for LAVENDER trial in US
|
|
Noda
|
83 |
29K |
3 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
83
|
29K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Change of Director's Interest Notice
|
|
Noda
|
7 |
4.1K |
6 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
7
|
4.1K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Temporary pause in new enrolments for LAVENDER trial in US
|
|
Noda
|
83 |
29K |
4 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
83
|
29K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
85
|
35K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
0 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
85
|
35K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
3 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
85
|
35K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
4 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
85
|
35K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
0 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
85
|
35K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
3 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
85
|
35K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Noda
|
85 |
35K |
5 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
85
|
35K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren to capture substantially greater value after Phase 3
|
|
Noda
|
96 |
37K |
6 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
96
|
37K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Stimulus Package
|
|
Noda
|
11 |
4.7K |
0 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
11
|
4.7K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Stimulus Package
|
|
Noda
|
11 |
4.7K |
7 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
11
|
4.7K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Compelling results for 2591 dose ranging study in PMS model
|
|
Noda
|
44 |
22K |
16 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
44
|
22K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Bell Potter Daily Bulletin
|
|
Noda
|
8 |
4.0K |
15 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
8
|
4.0K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Unbelievable....
|
|
Noda
|
31 |
14K |
22 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
31
|
14K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Noda
|
467 |
2.3M |
6 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
467
|
2.3M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2019 year-end update and 2020 outlook
|
|
Noda
|
171 |
118K |
12 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
171
|
118K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Getting thumped
|
|
Noda
|
15 |
9.0K |
4 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
15
|
9.0K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
What if....
|
|
Noda
|
46 |
26K |
3 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
46
|
26K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Patent to 2034 granted in Europe for Neuren's NNZ-2591
|
|
Noda
|
20 |
14K |
6 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
20
|
14K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Bell Potter lifts target to A$4.40/Share Vs A$3.75
|
|
Noda
|
109 |
81K |
0 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
109
|
81K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Bell Potter lifts target to A$4.40/Share Vs A$3.75
|
|
Noda
|
109 |
81K |
20 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
109
|
81K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Bell Potter lifts target to A$4.40/Share Vs A$3.75
|
|
Noda
|
109 |
81K |
4 |
22/11/19 |
22/11/19 |
ASX - By Stock
|
109
|
81K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Mst access report
|
|
Noda
|
22 |
17K |
2 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
22
|
17K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Bell Potter lifts target to A$4.40/Share Vs A$3.75
|
|
Noda
|
109 |
81K |
2 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
109
|
81K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Head to head
|
|
Noda
|
40 |
25K |
39 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
40
|
25K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Head to head
|
|
Noda
|
40 |
25K |
8 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
40
|
25K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 3 trial of trofinetide in Rett syndrome commences
|
|
Noda
|
47 |
28K |
6 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
47
|
28K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren Corporate Presentation, October 2019
|
|
Noda
|
80 |
61K |
1 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
80
|
61K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren Corporate Presentation, October 2019
|
|
Noda
|
80 |
61K |
6 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
80
|
61K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Appendix 4C - quarterly
|
|
Noda
|
24 |
18K |
5 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
24
|
18K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA grants Orphan for both Phelan-McDermid and Pitt Hopkins
|
|
Noda
|
57 |
36K |
4 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
57
|
36K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Pause in Trading
|
|
Noda
|
19 |
9.6K |
7 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
19
|
9.6K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
CR for Acadia
|
|
Noda
|
41 |
31K |
13 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
41
|
31K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren approaching key milestones in Q4 2019
|
|
Noda
|
145 |
75K |
7 |
24/09/19 |
24/09/19 |
ASX - By Stock
|
145
|
75K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren approaching key milestones in Q4 2019
|
|
Noda
|
145 |
75K |
29 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
145
|
75K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
CR for Acadia
|
|
Noda
|
41 |
31K |
11 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
41
|
31K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA BOOM !!!!
|
|
Noda
|
31 |
24K |
8 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
31
|
24K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA BOOM !!!!
|
|
Noda
|
31 |
24K |
9 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
31
|
24K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - Cracking the $200m m/cap again.
|
|
Noda
|
107 |
75K |
23 |
04/09/19 |
04/09/19 |
ASX - By Stock
|
107
|
75K
|
23
|
|